https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”).
$86
$123
2020PF 2021
$0.53
$0.89
2020PF 2021
Q1 2021 – ORGANIC PERFORMANCE
( T O TA L C O M PA N Y )
3
Sales Adjusted Operating Income
$991
$1,162
2020PF 2021
+ 17%
Adjusted EPS
+ 43% + 68%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
Q1 2021 SEGMENT PERFORMANCE
4
CAI
$536
$609
Sales
($ in millions)
SEM Distribution
$64
$89
Operating Income
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
+14%
+39%
$290
$363
Sales
$19
$24
Operating Income
+25%
+26%
(1)
$185
$217
Sales
$22
$34
Operating Income
+17%
+55%
SPECIALTY EBITDA MARGIN EXPANSION
5
CAI
(1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
15.3% 15.2%
16.2%
19.1%
2018 2019 2020 Q1 2021
14.8% 15.2%
17.6%
19.4%
2018 2019 2020 Q1 2021
(1)
SEM
• Continued portfolio transformation to
high-growth end markets and
sustainable solutions
• Clariant Masterbatch synergy realization
• Investments in composites and outdoor
high performance applications drive
growth and mix improvements
CAI EBITDA MARGIN EXPANSION
6
Legacy CAI
18.9% 18.9%
21.0%
2019 2020 Q1 2021
Legacy
Clariant MB
11.9%
13.8%
17.4%
2019 2020 Q1 2021
• Early synergy capture translating to
the bottom line
• Positive mix with growth in healthcare,
consumer and packaging end-markets
• World-class vitality index of 36%
represents sales from products
introduced in the last five years.
We will deliver for our stakeholders through multiple value creation levers—many of
which are unique to Avient:
o Demand for sustainable solutions, healthcare, and composites, together with Clariant
Masterbatch revenue synergies, that will drive 2021 revenue growth of 14% and long-term
growth in excess of GDP
o Clariant Masterbatch cost synergy capture will result in significant near-term benefit
In addition, we remain committed to increasing annual dividends in line with earnings growth and
opportunistically buying back shares, all while remaining modestly levered.